219 related articles for article (PubMed ID: 22350790)
1. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
Schwarzenbach H; Milde-Langosch K; Steinbach B; Müller V; Pantel K
Breast Cancer Res Treat; 2012 Aug; 134(3):933-41. PubMed ID: 22350790
[TBL] [Abstract][Full Text] [Related]
2. [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features].
Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Hu XQ
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2833-7. PubMed ID: 19080492
[TBL] [Abstract][Full Text] [Related]
3. Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development.
Ali SA; Abdulrahman ZFA; Faraidun HN
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):44-50. PubMed ID: 33287921
[TBL] [Abstract][Full Text] [Related]
4. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.
Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Shen X; You J; Hu XQ
Oncol Rep; 2009 Mar; 21(3):673-9. PubMed ID: 19212625
[TBL] [Abstract][Full Text] [Related]
6. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.
Eichelser C; Flesch-Janys D; Chang-Claude J; Pantel K; Schwarzenbach H
Clin Chem; 2013 Oct; 59(10):1489-96. PubMed ID: 23748853
[TBL] [Abstract][Full Text] [Related]
7. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
8. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
9. MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
Zhao D; Chen Y; Chen S; Zheng C; Hu J; Luo S
Tumour Biol; 2017 May; 39(5):1010428317705341. PubMed ID: 28475001
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
13. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.
Eichelser C; Stückrath I; Müller V; Milde-Langosch K; Wikman H; Pantel K; Schwarzenbach H
Oncotarget; 2014 Oct; 5(20):9650-63. PubMed ID: 25333260
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-155, let-7c, miR-21, and PTEN levels in differential diagnosis and prognosis of idiopathic granulomatous mastitis and breast cancer.
Aksan H; Kundaktepe BP; Sayili U; Velidedeoglu M; Simsek G; Koksal S; Gelisgen R; Yaylim I; Uzun H
Biofactors; 2020 Nov; 46(6):955-962. PubMed ID: 32941675
[TBL] [Abstract][Full Text] [Related]
16. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
17. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑142‑5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog.
Xu W; Wang W
Mol Med Rep; 2018 Jun; 17(6):7529-7536. PubMed ID: 29620260
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
20. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
